- Drug Pipelines
- January 2022
- 30 Pages
Global
From €455EUR$500USD£390GBP
Cholbam is a market of drugs used to treat liver and kidney disorders. It is composed of medications that are used to treat a variety of conditions, including hepatitis, cirrhosis, and kidney failure. These drugs are used to reduce inflammation, improve liver and kidney function, and reduce the risk of complications. Cholbam is a combination of two drugs, cholic acid and bile acid, which are used to treat a variety of liver and kidney disorders. The drugs are available in both oral and injectable forms.
Cholbam is a relatively new market, but it is growing rapidly. It is becoming increasingly popular as a treatment option for liver and kidney disorders due to its effectiveness and safety.
Companies in the Cholbam market include AbbVie, Allergan, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more